Cantabio Pharmaceuticals Inc.
Cantabio Pharmaceuticals Inc. (CTBO) is a publicly traded company in the Unknown sector. Across all available filings, 1 corporate insiders have executed 5 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Sep 12, 2018 involved a transaction of 7,352,941 shares valued at $0.
CTBO Insider Activity Summary
Who Is Buying CTBO Stock?
No significant insider buying has been recorded for CTBO in the recent period.
Who Is Selling CTBO Stock?
No significant insider selling has been recorded for CTBO in the recent period.
Is Cantabio Pharmaceuticals Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CTBO is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
CTBO Frequently Asked Questions
Understanding CTBO Insider Activity
Insider trading at Cantabio Pharmaceuticals Inc. (CTBO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 1 insiders are actively trading CTBO stock, having executed 5 transactions in the past 90 days. The most active insider is Gergely Toth (Executive), who has made 5 transactions totaling $0.
Related Tools
Track Cantabio Pharmaceuticals Inc. Insider Activity
Get notified when executives and directors at CTBO file new Form 4 transactions